Sunday, July 5, 2026 — While U.S. markets are closed for the weekend, institutional traders are already positioning for what's shaping up to be one of the most consequential earnings weeks of 2026. The next five trading days (July 13-17) will feature 15+ major names across financials, healthcare, technology, and industrials — a slate that could reset sector leadership and reshape positioning through the second half of the year.

The financial sector takes center stage early. JPMorgan Chase, Bank of America, Goldman Sachs, Wells Fargo, and Morgan Stanley will report earnings Monday through Wednesday morning. These five institutions represent the backbone of U.S. capital markets, and their guidance on net interest margins, investment banking fees, and loan loss provisions will telegraph the health of credit cycles, dealmaking activity, and consumer health heading into Q3.

Key Takeaways

  • JPMorgan, Bank of America, Goldman Sachs, Wells Fargo, and Morgan Stanley report Monday-Wednesday; net interest margin guidance critical for Fed rate expectations.
  • UnitedHealth ($111.91B revenue expected) reports Wednesday before market; healthcare sector leadership and insurance pricing power at stake.
  • Netflix reports Thursday after hours ($12.84B revenue est); subscriber growth and advertising tier adoption will set tone for streaming profitability thesis.

The Financial Sector Setup: Watch Net Interest Margin Guidance

JPMorgan Chase leads the charge Monday morning with consensus EPS of $5.5819 on $49.62B revenue. Traders will scrutinize two metrics: (1) net interest margin compression — a quarter of tighter lending spreads would pressure 2026 earnings — and (2) investment banking revenue from the recent M&A wave. Last week's micro-cap rally suggests retail appetite for risk, which typically translates into higher capital markets activity.

Bank of America and Wells Fargo follow Monday morning before market open. BAC consensus sits at $1.1178 EPS on $30.71B revenue; WFC at $1.7272 EPS on $22.01B revenue. Both face headwinds on net interest income, but WFC's consumer lending franchise and BAC's wealth management division offer upside surprises if loan demand unexpectedly strengthened in early Q2.

Goldman Sachs reports Tuesday morning — a $14.1578 consensus EPS speaks to capital intensity and dealmaking leverage. The massive EPS number reflects Goldman's concentrated revenue streams. Any guidance miss here ripples through banking and equity syndication narratives. Citigroup reports Tuesday as well ($2.7463 EPS est), while Morgan Stanley waits until Wednesday morning ($2.8624 EPS).

The collective theme: If the financial cohort guides to margin stabilization and rising capital markets fees, the market rewards the entire sector. If margin compression persists and M&A cools, expect rotation into defensives.

Healthcare Heavyweight Week: UnitedHealth, Johnson & Johnson, Abbott Lead

UnitedHealth is the earnings monster of the week — $111.91B revenue expected on $4.8914 EPS, reported Wednesday before market. As the largest U.S. health insurer, UNH's earnings are a referendum on three things: (1) medical loss ratios (claims vs. premiums), (2) administrative efficiency, and (3) pricing power into 2027. If UNH guides to strong profit margins despite inflation in care costs, healthcare defensive stories outperform. If claims accelerate, expect a sector sell-off.

Johnson & Johnson reports Wednesday afternoon ($2.8722 EPS, $25.24B revenue). As a pharma-device-consumer health hybrid, JNJ's guidance on drug pricing, new launches, and surgical volume will influence the entire healthcare sector's valuation multiple. Watch for any commentary on GLP-1 competitive dynamics — a pricing war in obesity drugs would pressure pharma margins.

Abbott Laboratories reports Wednesday before market ($1.2926 EPS, $12.65B revenue). Abbott's exposure to diagnostics, electrophysiology devices, and nutrition products gives it a broader cyclical lens. Strong guidance would confirm the healthcare sector's resilience.

Healthcare sector leadership over the past three months has been a function of defensive positioning, but earnings week could reignite growth narratives if companies guide to pricing power.

Technology and Discretionary: Netflix, Snap Lead the Charge

Netflix is the marquee tech play of the week, reporting Thursday after market close ($0.8041 EPS, $12.84B revenue). The streaming giant's battle is two-fold: (1) proving that paid sharing crackdowns and ad tier adoption drive durable margin expansion, and (2) maintaining subscriber momentum in a saturated U.S. market. Netflix guides for future quarters; any slowdown in international sub growth or weakness in ad revenue ARPU would be a red flag for the broader ad-tech sector.

Snapchat reports Thursday ($0.0835 EPS, $1.57B revenue). Snap's real test is ad demand in early Q3 — if Snap guides to strong advertiser spend despite macro uncertainty, the entire ad-tech cohort rallies. Conversely, weakness suggests consumer spending is cooling faster than consensus expects.

BlackRock reports Wednesday ($12.6481 EPS, $6.82B revenue). As the world's largest asset manager, BLK's earnings will reflect ETF flows, active management redemptions, and alternative asset fundraising. Strong guidance would confirm institutional capital rotation narratives.

Airlines and Industrials: Cyclical Sensitivity Tests

United Airlines reports Wednesday ($1.7228 EPS, $17.74B revenue), while American Airlines reports Thursday ($-0.0252 EPS, $16.82B revenue). The airline cohort provides a real-time snapshot of travel demand, fuel costs, and labor negotiation impacts. Strong summer guidance would suggest consumer health remains intact; weakness would accelerate recession fears.

General Electric reports Thursday before market ($1.9165 EPS, $12.13B revenue). GE's guidance on industrial orders, aerospace demand, and energy transition capital expenditures carries macro weight — if corporate CapEx guidance is strong, growth narratives survive. If companies pull back, expect multiple compression.

What This Earnings Week Means for Market Positioning

The last time we saw this concentration of mega-cap earnings was Q1 2025, which preceded a 12.8% rally in the broad market. The pattern then: financial guidance that stabilized rate expectations, healthcare pricing power confirmed, and tech guidance that supported valuation multiples.

The variable that could shift this week: Fed commentary. If James Bullard or any other Fed speaker signals rate cuts in fall 2026, financials rally. If rate-hike signals persist, defensive plays like UNH and JNJ outperform, and cyclical names like UAL and GE disappoint.

Volatility traders are pricing a 3.2% move in the S&P 500 for the week — above the 2.1% average. This suggests the market understands earnings week as a potential inflection point for sector leadership.

How to Prepare: Key Dates and Times

Monday, July 14 (Before Open): JPM, BAC, WFC, GS (partial)

Monday, July 14 (Afternoon): JPM conference call, Citi investor call

Tuesday, July 15 (Before Open): MS, ABT, BLK, JNJ conference calls

Wednesday, July 16 (Before Open): UNH, GE, JNJ (if not Tuesday), GS (if not Monday)

Thursday, July 17 (After Close): NFLX, SNAP reporting; Netflix earnings call typically 4:30 PM ET

For the complete earnings calendar and all earnings dates, visit our earnings calendar for real-time updates on conference call times and guidance revisions.

The week ahead will determine whether financials re-rate higher on stabilizing margins, whether healthcare solidifies its defensive crown, and whether tech valuations can hold amid rising competition and margin pressure. Positioning now matters.

Frequently Asked Questions

When do the big bank earnings come out?

JPMorgan, Bank of America, Wells Fargo, and Goldman Sachs report Monday, July 14 before market open. Citigroup and Morgan Stanley report Tuesday and Wednesday mornings. All five are expected to discuss net interest margin trends, investment banking activity, and loan loss reserves.

What's the consensus EPS for JPMorgan Chase?

JPMorgan consensus EPS is $5.5819 on revenue of $49.62B. The key metric traders watch is net interest margin guidance — if JPM's NIM stabilizes or expands, the financial sector rallies. Any compression guidance could trigger selling.

When does UnitedHealth report and why does it matter?

UnitedHealth reports Wednesday, July 16 before market open with an expected $4.8914 EPS and $111.91B revenue. As the largest U.S. health insurer, UNH's earnings indicate whether medical cost inflation is being offset by pricing power. This sets the tone for the entire healthcare sector.

What's Netflix's earnings estimate?

Netflix is expected to report $0.8041 EPS on $12.84B revenue Thursday, July 17 after market close. Investors focus on paid-sharing crackdown impact, subscriber growth (especially outside the U.S.), and ad tier ARPU — proof that advertising adoption is durable profit driver.

Which earnings could move the S&P 500 the most?

JPMorgan, UnitedHealth, and Netflix combined represent ~$12 trillion in market cap. Their guidance on credit cycles, healthcare inflation, and tech advertising momentum can shift sector leadership and reset positioning through Q3 2026. Financial guidance is typically the heaviest influence on index momentum.

Looking Ahead

This earnings cycle is a referendum on three core market narratives: (1) Can financials justify higher valuations without margin expansion?, (2) Will healthcare sustain premium multiples on pricing power?, (3) Can tech growth stories survive if ad demand cools? The answers land next week.

Last week's micro-cap rally showed retail conviction in risk-on positioning. This week's earnings determine whether institutional capital follows. The stakes are visibility on Q3 earnings power, Fed rate path clarity, and sector rotation catalysts through year-end.